Results 91 to 100 of about 876 (115)

Favipiravir induces oxidative stress and genotoxicity in cardiac and skin cells

Toxicology Letters, 2022
Tuğçe Boran
exaly  

Alectinib, COVID-19 and favipiravir

Journal of Oncology Pharmacy Practice, 2021
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit   +1 more
openaire   +2 more sources

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study

Journal of Infection and Chemotherapy, 2023
Takuma Ishihara, Yohei Doi, Masahiko Ando   +2 more
exaly  

Favipiravir, an antiviral for COVID-19?

Journal of Antimicrobial Chemotherapy, 2020
Hourmazd Haghbayan, Eric Coomes
exaly  

Favipiravir for children with Ebola

The Lancet, 2015
Bouazza, Naïm, Treluyer, Jean-Marc, Foissac, Frantz, Mentré, France, Taburet, Anne-Marie, Guedj, Jérémie, Anglaret, Xavier, de Lamballerie, Xavier, Keïta, Sakoba, Malvy, Denis, Frange, Pierre   +10 more
openaire   +2 more sources

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus

Microorganisms, 2021
Sylvia Rothenberger, Olivier Engler, Jennifer Mayor   +2 more
exaly  

Favipiravir exposure and pregnancy outcome of COVID-19 patients

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2022
exaly  

Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2021
Duygu Eryavuz Onmaz, Sedat Abuşoǧlu, Fatma Hümeyra Yerlikaya   +2 more
exaly  

Favipiravir

Reactions Weekly
openaire   +2 more sources

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Antiviral Research, 2013
Brian Gowen, Donald Smee, Kimiyasu Shiraki   +2 more
exaly